Mindstrong Health

Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Mindstrong creates a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques.

Mindstrong enables its members to get access to care whenever they need it, with its clinical staff offering cognitive-based therapy and medication management via the Mindstrong app. Its patented set of digital markers measures brain function through passive interaction patterns captured via the smartphone, and these are used alongside traditional assessments to help create a better picture of a person's mental health. Mindstrong helps those with serious mental illnesses such as bipolar disorder, major depressive disorder and schizophrenia.

Mindstrong opened a new office in San Francisco in early 2020, in addition to its HQ in Mountain View, California.

In May 2020 the company raised a $100m Series C round, with investors including General Catalyst, 8VC and more.